BioSpace News Archive

AlzeCure Changes Direction for its Drug Candidate ACD855 Within the NeuroRestore Platform

AlzeCure Pharma AB announced that they will redirect the drug candidate ACD855 within the research platform NeuroRestore from cognitive dysfunction to an indication in the eye instead.

May 3, 2019
·
2 min read
Business

Washington Hospital CEO of 25 Years Nancy D. Farber to Retire

Led Hospital from Small Rural Hospital to Renowned Regional Healthcare System

May 3, 2019
·
7 min read
Business

St. Baldrick’s Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery

St. Baldrick’s Robert J. Arceci Innovation Award provides scientists opportunity to pursue unrestricted research

May 3, 2019
·
5 min read
Major Initiative to Close Information Gaps on Cross Border Reproduction in the Asia Pacific

A powerful task force of scientists and clinicians specialising in assisted conception have mounted a major campaign to close gaps in knowledge about cross border reproduction in the Asia Pacific region.

May 3, 2019
·
3 min read
Business

Yeshiva University Opens Newly Upgraded Mental Health and Training Clinic at Ferkauf Graduate School of Psychology in the Bronx

Parnes Clinic Continues to Offer Enhanced and Affordable Services to Bronx Residents in New State-of-the-Art Facilities

May 3, 2019
·
7 min read
Deals

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - May 3, 2019

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on May 3, 2019 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 49,125 shares of Puma common stock to nine new non-executive employees.

May 3, 2019
·
2 min read
Deals

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 3, 2019

PTC Therapeutics, Inc. announced that on April 23, 2019 it approved non-statutory stock options to purchase an aggregate of 210,900 shares of its common stock to 27 new employees.

May 3, 2019
·
1 min read
BioMidwest

OS, Inc. Provides Notice to Covered Entities and Patients About a Data Security Incident

OS, Inc. announced that a phishing email campaign may have resulted in unauthorized access to personal information contained within an OS employee’s email account.

May 3, 2019
·
3 min read
Drug Development

The Italian R&D Excellence at the American Urological Association’s 2019 Annual Meeting

Preliminary data show Oncofid®P-B is very well tolerated and has promising efficacy when administered for up to 12 consecutive weeks in BCG unresponsive/intolerant patients with bladder carcinoma in situ (CIS)

May 3, 2019
·
5 min read
Business

Adaptive Biotechnologies Appoints Francis Lo as Chief People Officer

Adaptive Biotechnologies announced the appointment of Francis Lo as Chief People Officer, overseeing development and execution of the company’s Human Capital strategy.

May 3, 2019
·
2 min read